SGMO
Sangamo Therapeutics, IncCompany with tickers: SGMO
CIK
1001233
CUSIP
800677106
Shares Outstanding
414,288,847
13F Activity (30d)
65 filings
63 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2020-01-24 | Macrae Sandy |
Director, PRESIDENT, CEO AND DIRECTOR | Tax | 4,283 |
| 2020-02-11 | Markels John |
Director | Award | 5,000 |
| 2020-02-11 | Markels John |
Director | Award | 30,000 |
| 2020-02-11 | Markels John |
Director | Other | 0 |
| 2020-02-25 | Duraibabu Prathyusha |
Director | Award | 33,000 |
| 2020-02-25 | Macrae Sandy |
Director, PRESIDENT, CEO AND DIRECTOR | Award | 337,500 |
| 2020-02-25 | Ramelmeier Rolf Andrew |
EVP, Technical Operations | Award | 55,000 |
| 2020-02-25 | Lee Sung |
Director | Award | 100,500 |
| 2020-02-25 | Boissel Stephane |
EVP, Corp. Strategy | Award | 110,000 |
| 2020-02-25 | Macrae Sandy |
Director, PRESIDENT, CEO AND DIRECTOR | Tax | 7,264 |
| 2020-02-25 | Woolfson Adrian |
EVP Research & Development | Award | 50,000 |
| 2020-02-25 | LOEB GARY |
EVP, General Counsel & Sec. | Award | 100,000 |
| 2020-02-25 | Macrae Sandy |
Director, PRESIDENT, CEO AND DIRECTOR | Award | 168,750 |
| 2020-02-25 | Duraibabu Prathyusha |
Director | Award | 16,500 |
| 2020-02-25 | Woolfson Adrian |
EVP Research & Development | Award | 100,000 |
| 2020-02-25 | Ramelmeier Rolf Andrew |
EVP, Technical Operations | Award | 110,000 |
| 2020-02-25 | Ramelmeier Rolf Andrew |
EVP, Technical Operations | Tax | 1,703 |
| 2020-02-25 | Lee Sung |
Director | Award | 50,000 |
| 2020-02-25 | Boissel Stephane |
EVP, Corp. Strategy | Tax | 2,384 |
| 2020-02-25 | LOEB GARY |
EVP, General Counsel & Sec. | Award | 500,000 |
| 2020-02-25 | Boissel Stephane |
EVP, Corp. Strategy | Award | 55,000 |
| 2020-03-12 | Zakrzewski Joseph S |
Director | Buy | 15,000 |
| 2020-03-13 | Zakrzewski Joseph S |
Director | Buy | 5,000 |
| 2020-03-16 | DILLY STEPHEN GEORGE |
Director | Convert | 15,000 |
| 2020-03-16 | DILLY STEPHEN GEORGE |
Director | Sell | 15,000 |
| 2020-03-16 | DILLY STEPHEN GEORGE |
Director | Convert | 15,000 |
| 2020-03-17 | Zakrzewski Joseph S |
Director | Buy | 5,000 |
| 2020-03-18 | PARKER H STEWART |
Director | Buy | 3,000 |
| 2020-03-19 | DILLY STEPHEN GEORGE |
Director | Convert | 35,000 |
| 2020-03-19 | DILLY STEPHEN GEORGE |
Director | Convert | 35,000 |
| 2020-03-19 | DILLY STEPHEN GEORGE |
Director | Sell | 35,000 |
| 2020-03-25 | Duraibabu Prathyusha |
Director | Award | 3,000 |
| 2020-04-08 | BIOGEN INC. |
10% Owner | Other | 24,420,157 |
| 2020-04-25 | Duraibabu Prathyusha |
Director | Tax | 647 |
| 2020-05-01 | McClung David Mark |
EVP, Chief Operating Officer | Other | 0 |
| 2020-05-09 | Boissel Stephane |
EVP, Corp. Strategy | Expiration | 1 |
| 2020-05-18 | Carey Robert |
Director | Award | 2,500 |
| 2020-05-18 | Ramasastry Saira |
Director | Award | 2,500 |
| 2020-05-18 | Smith Karen L. |
EVP, Chief Medical Officer | Award | 2,500 |
| 2020-05-18 | Ramasastry Saira |
Director | Award | 15,000 |
| 2020-05-18 | Zakrzewski Joseph S |
Director | Award | 2,500 |
| 2020-05-18 | Zakrzewski Joseph S |
Director | Award | 15,000 |
| 2020-05-18 | DILLY STEPHEN GEORGE |
Director | Award | 2,500 |
| 2020-05-18 | PARKER H STEWART |
Director | Award | 15,000 |
| 2020-05-18 | DILLY STEPHEN GEORGE |
Director | Award | 15,000 |
| 2020-05-18 | Meyers James R |
Director | Award | 15,000 |
| 2020-05-18 | Smith Karen L. |
EVP, Chief Medical Officer | Award | 15,000 |
| 2020-05-18 | Meyers James R |
Director | Award | 2,500 |
| 2020-05-18 | Carey Robert |
Director | Award | 15,000 |
| 2020-05-18 | PARKER H STEWART |
Director | Award | 2,500 |
Showing 1–50 of 436 transactions